Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

A comparison of 2 different combinations of high blood pressure medications to treat hypertension

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daiichi Sankyo Inc.; Daiichi Sankyo, Inc.
• Treatments: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benazepril; Calcium Channel Blockers; Calcium, Dietary; Hydrochlorothiazide; Olmesartan; Olmesartan Medoxomil

Criteria

Inclusion Criteria:

• Greater than 18 years of age

• Patients with high blood pressure

Exclusion Criteria:

• Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months

• History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months

• Type 1 diabetes mellitus